February 14, 2008 - A new approach called Hybrid Maze combines techniques from two existing procedures to offer patients a minimally invasive treatment for atrial fibrillation.

February 14, 2008 - At age 20, Vanessa Cirillo suffered a heart attack caused by a virus. She recovered and lived a healthy life until June 2007, when her heart condition became critical. Her heart had enlarged several times its normal size (cardiomyopathy). It was no longer pumping enough blood to sustain her body. She needed a heart transplant but no donor heart was available. To save her life, she was flown from a Las Vegas hospital to University Medical Center (UMC) in Tucson, AZ.

February 13, 2008 – MEDRAD Inc. delivered the 10,000th Mark V ProVis Angiography Injection System, which is used worldwide for live imaging during therapeutic interventions and diagnostic angiography procedures, demonstrating consistent demand for the system in cardiology, interventional radiology and vascular surgery despite a trend toward noninvasive CT and MR for diagnostic procedures.


February 13, 2008 - Orqis Medical Corp’s MOMENTUM Trial Abstract was accepted for a late breaking clinical trial presentation at the upcoming American College of Cardiology (ACC) meeting, in which it will report on the hemodynamic and clinical effects of the percutaneous Cancion System in managing patients hospitalized with heart failure.

February 13, 2008 - Nfocus Neuromedical Inc. announced that the company has received CE mark approval for the CardioVasc Stent-Graft and Delivery System, a minimally invasive device for treating patients with Saphenous Vein Graft Lesions (SVGs) from a previous coronary bypass, Vessel Perforations and Coronary Artery Aneurysms.

Biosound Esaote will feature the QIMT module for the MyLab platforms at ACC 2008.


Foremost on the minds of many radiologists today is how to reduce radiation dose when using computed tomography (CT) without compromising image quality.


February 12, 2008 - Boston Scientific Corp. reported that a U.S. District Court jury in Marshall, TX, has reached a verdict in favor of Bruce Saffran, M.D., over a patent infringement on drug-eluting stents, a decision which Boston Scientific plans to appeal.

The jury found that the Company's TAXUS Express and TAXUS Liberte drug-eluting stent products infringe Dr. Saffran's patent and that the patent is valid. No injunction was requested, but the jury awarded damages of $431 million.

February 12, 2008 – KLAS named Philips the KLAS General Market Software Category Leader for Cardiology Reporting & Documentation and the General Market Software Category Leader for Cardiology Hemodynamics, designating Philips as the only vendor to win two KLAS awards for cardiology technologies in the 2007 Top 20 Year End Best in KLAS Awards.

February 12, 2008 - The Dictaphone Healthcare Solutions division of Nuance is now offering the Revolabs xTag Wireless Microphone alongside its Dragon NaturallySpeaking Medical speech recognition software solution.

Subscribe Now